Clene Inc.
CLNN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001822791
No open-market purchases or sales by Clene Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $19.6M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Clene Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 50 | 47 | −3 |
| Shares | 32.3M | 24.6M | −7.66M (−23.7%) |
| Value | $28.1M | $12.3M | −$15.8M (−56.3%) |
New holders (5)
Institutions that held Clene Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 163,911 | $81.0K | 0.00% |
| Csenge Advisory Group | 116,600 | $57.8K | 0.00% |
| HRT Financial LP | 31,771 | $15.0K | 0.00% |
| Key Client Fiduciary Advisors, LLC | 26,000 | $12.9K | 0.01% |
| Pathstone Family Office, LLC | 25,230 | $12.5K | 0.00% |
Sold out (8)
Institutions that held Clene Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Acuta Capital Partners, LLC | 4,240,846 | $3.73M |
| Hudson Bay Capital Management LP | 1,378,600 | $1.21M |
| Partners Capital Investment Group, LLP | 67,855 | $59.7K |
| Veritable, L.P. | 25,230 | $22.2K |
| Two Sigma Securities, LLC | 21,266 | $18.7K |
| Belpointe Asset Management LLC | 14,900 | $13.1K |
| Group One Trading, L.P. | 5,738 | $5.05K |
| IFP Advisors, Inc | 400 | – |